Overview
At the intersection of Biology and Chemical Engineering we can find today’s best chance to replace humanity’s reliance on petrochemicals: Biomanufacturing. It is a way to use living organisms to create compounds that we commonly get from petroleum. Thanks to breakthroughs in discovering pathways, genetic engineering, and bioprocessing, we can leverage Synthetic Biology to tweak microorganisms, figure out how they work, and optimize them to produce large amounts of useful substances. This opens the door to a future where biomanufacturing could help us achieve sustainable development goals and offer a genuinely earth-friendly alternative to non-renewable resources.
Join us for an exclusive event delving into the cutting-edge realm of biomanufacturing, where groundbreaking advancements and transformative technologies converge. Hear from renowned experts to explore the limitless possibilities of biomanufacturing. Engage in thought-provoking discussions on the latest advancements and challenges in the field. Connect with peers, industry leaders, and potential collaborators.
Schedule
Date: 08 Apr 2024, Monday
Time: 4:00 PM - 6:00 PM (GMT +8:00) Kuala Lumpur, Singapore
Location: Huone Theatre Room, 3D River Valley Rd, #03-01 Block D3, 179023
Speakers
Speaker's Profile:
Prof Poh Chueh Loo, Associate Professor, National University of Singapore (NUS)
Professor Poh obtained a PhD in Bioengineering from Imperial College London, UK and a Bachelor of Engineering (Electrical & Electronic) with Honours (First Class) from Nanyang Technological University (NTU), Singapore. Professor Poh is interested in the development of new tools for synthetic biology and in the use of a model-based approach for biodesign.
Speaker's Profile:
Prof Li Zhi , Associate Professor, National University of Singapore (NUS)
Prof. Li Zhi received B.Sc. in chemistry from Nanjing University in 1982, M. Eng. in chemical engineering from Chinese Academy of Forestry in 1985, and Ph.D. in organic chemistry from the University of Vienna in 1991. In 2006 he moved to National University of Singapore as an associate professor at the Department of Chemical and Biomolecular Engineering. He was a fellow of the Singapore-MIT Alliance (2006–2015). His research focuses on biocatalysis for chemical synthesis, especially for enantioselective synthesis and green pharmaceutical manufacturing; bio-based chemical and fuel production; and polymeric biomaterials. His expertise in biocatalysis includes enzyme discovery and evolution, cascade biotransformations, enzyme immobilization, biotransformations in vivo and in vitro, and bioprocess development. He received Singapore Award for Sustainable Technology from IChemE (2013) and Achievement Award from Bioenergy Society of Singapore (2018).
Speaker's Profile:
Dr Kostas Vavitsas, Deputy Program Director, TeOra
Dr Kostas Vavitsas is Deputy Program Director at TeOra, a Singapore startup using cutting edge technology to provide disease management solutions for aquaculture. He holds a PhD in Biotechnology from the University of Copenhagen, and he has conducted research in Australia, Greece, Denmark, and Sweden. He was previously heading Singapore's Consortium for Synthetic Biology and he is a well-regarded member of the global Synthetic Biology Community.
Moderator's Profile:
Dr Ang Huiying, Associate Director, Technology Transfer & Innovation, NUS Enterprise
Dr Huiying Ang is an associate director in NUS Technology Transfer and Innovation (TTI) office and an adjunct assistant professor with the department of biomedical engineering. She completed her Ph.D in Materials Science and Engineering and was the MedTech Lead at National Heart Centre Singapore for 6 years before joining NUS. She has extensive background in medical device research and innovation, in-depth training in design thinking and deep tech translation. At NUS TTI, she is part of a team that leads the charge in commercialisation of NUS health technologies portfolio. Huiying works closely with researchers and healthcare start-ups to transform scientific innovations into real-world solutions. She maintains close collaborations with key stakeholders in the MedTech ecosystem, forging connections between academia, investors, and industry.
